N 739 150 (Mexiletine 150 mg)
Pill imprint N 739 150 has been identified as Mexiletine hydrochloride 150 mg.
Mexiletine is used in the treatment of ventricular tachycardia; myotonia congenita; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for N 739 150 (Mexiletine 150 mg)
- Imprint:
-
N 739
150 - Strength:
- 150 mg
- Color:
- Tan / Orange
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-8739
- Inactive Ingredients:
- silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
gelatin
titanium dioxide
ammonia
ferrosoferric oxide
D&C Yellow No. 10
alcohol
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
shellac
D&C Red No. 28
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55045-3634 | Dispensing Solutions Inc. (repackager) |
| 49999-0916 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More resources
Mexiletine hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

